November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Tuesday that its consolidated net profit increased to 67.9 million levs ($35.9 million/34.7 million euro) in the first nine months of 2022 from 50.5 million levs in the same period of 2021.